Carbidopa, Levodopa, and Entacapone 37.5 mg/1 (Carbidopa, Levodopa, and Entacapone TABLET, FILM COATED) 37.5 mg/1

Carbidopa, Levodopa, and Entacapone 37.5 mg/1 tablets are a combination medication used to manage symptoms of Parkinson's disease. This oral treatment helps improve muscle control and reduce tremors.

Strength

37.5 mg/1

Pack Size

100 TABLET, FILM COATED in 1 BOTTLE (0781-5654-01)

Manufacturer / TM Owner

Sandoz Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Carbidopa, Levodopa, and Entacapone 37.5 mg/1 tablets are primarily used to treat Parkinson's disease. The medication works by increasing the levels of dopamine in the brain, which helps to alleviate symptoms such as stiffness, tremors, and muscle spasms. This combination therapy is often prescribed when other treatments are not effective enough.

Side Effects

Common effects of Carbidopa, Levodopa, and Entacapone 37.5 mg/1 tablets may include nausea, dizziness, and headache. Some users may also experience drowsiness or involuntary movements. These effects vary and are not experienced by everyone.

Precautions & Warnings

It is important to handle Carbidopa, Levodopa, and Entacapone 37.5 mg/1 tablets with care. Store them in a cool, dry place away from direct sunlight. Always follow the instructions provided by your healthcare professional. Do not share this medication with others.

Avoid Interactions

Carbidopa, Levodopa, and Entacapone 37.5 mg/1 tablets may interact with certain medications, including antidepressants, antipsychotics, and blood pressure medications. Alcohol consumption should be avoided as it can increase the risk of side effects. Always consult a healthcare professional before starting any new medication.

Frequently Asked Questions

This medication is used to manage symptoms of Parkinson's disease, such as tremors and muscle stiffness.

Store the tablets in a cool, dry place away from direct sunlight and out of reach of children.

Common side effects may include nausea, dizziness, and headache. Some users may also experience drowsiness or involuntary movements.

It is advisable to avoid alcohol as it can increase the risk of side effects.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.